Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aligos Therapeutics, Inc.

11.67
+0.23002.01%
Volume:97.96K
Turnover:1.15M
Market Cap:71.35M
PE:-0.91
High:12.12
Open:11.49
Low:11.39
Close:11.44
Loading ...

Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition

TIPRANKS
·
12 Mar

Aligos Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
11 Mar

Aligos Therapeutics Advances Pipeline Amid Financial Challenges

TIPRANKS
·
11 Mar

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?

Benzinga
·
11 Mar

Aligos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Mar

BUZZ-Aligos Therapeutics falls on bigger Q4 loss

Reuters
·
11 Mar

BRIEF-Aligos Therapeutics reports fourth-quarter and full-year 2024 results

Reuters
·
10 Mar

Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
10 Mar

Aligos Therapeutics Q4 EPS $(13.08) Misses $(2.30) Estimate, Sales $629.00K Beat $433.33K Estimate

Benzinga
·
10 Mar

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
10 Mar

Aligos Therapeutics Inc expected to post a loss of $2.50 a share - Earnings Preview

Reuters
·
07 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025

GlobeNewswire
·
03 Mar

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Business Wire
·
27 Feb

Press Release: Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025

Dow Jones
·
13 Feb

Aligos Therapeutics Secures $105M in Private Placement

TIPRANKS
·
12 Feb